The agreement with Brazil was signed on March 26 by CIRM President Alan Trounson and Glaucius Oliva, president of Brazil's National Council for Scientific Technological Development.
You are here
Coverage of the latest news and updates from the field of stem cells.
"I think the only interpretation is that we are being censored," Alan Trounson, president of the California Institute for Regenerative Medicine in San Francisco, said in a statement. "It is very disappointing that they are unwilling to hear the truth."
The new reprogramming method, published in the current edition of Cell Stem Cell, builds on work by Japanese researcher Shinya Yamanaka and his team, who produced stem cells from the connective tissue cells of mice for the first time in 2006.
On March 19, Red underwent stem cell regenerative therapy at Burke Animal Clinic in Burke, Virginia (US).
Put together, these findings suggest it is possible to assemble human retinal cells into more complex retinal tissues, all starting from a routine patient blood sample.
Stem cell seeding has been successful in building less complex organs. In fact, just last November the second person in the world (and the first U.S. patient) received a trachea built from nanofibers seeded with his own stem cells in a procedure performed by Dr.
The bill would have provided that "unborn children at every stage of development enjoy all the rights, privileges and immunities available to other persons, citizens and residents of the commonwealth, subject only to the laws and constitutions of Virginia and the United States, precedents of the
"This is significant, because acceptance of these cells on the registry demonstrates our attention to details of proper oversight, consenting and following of NIH guidelines established in 2009," says Gary Smith, Ph.D., who derived the line and also is co-director of the University of Michigan (U
The study, led by Dr. Fred Roisen of RhinoCyte™ Inc., has great implication for the estimated 5 million people worldwide affected by spinal cord injuries - 1.275 million of them in the United States alone, where the cost of treatment exceeds $40.5 billion each year.
The move is part of Cytomedix's plan to expand from a wound-care based technology platform into a broader regenerative medicine company.